Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 549

1.

Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener's granulomatosis.

Chen M, Yu F, Wang SX, Zou WZ, Zhang Y, Zhao MH, Wang HY.

Nephrol Dial Transplant. 2007 Jan;22(1):139-45. Epub 2006 Sep 15.

PMID:
16980322
3.

IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.

Liu LJ, Chen M, Yu F, Zhao MH, Wang HY.

Nephrology (Carlton). 2008 Oct;13(7):629-35. doi: 10.1111/j.1440-1797.2008.00976.x. Epub 2008 Sep 3.

PMID:
18775059
5.

T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).

Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG.

Clin Exp Immunol. 1994 Dec;98(3):448-53.

6.

Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.

Schönermarck U, Lamprecht P, Csernok E, Gross WL.

Rheumatology (Oxford). 2001 Feb;40(2):178-84.

PMID:
11257154
7.

Characteristics of Chinese patients with Wegener's granulomatosis with anti-myeloperoxidase autoantibodies.

Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY.

Kidney Int. 2005 Nov;68(5):2225-9.

8.

Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.

Am J Kidney Dis. 2003 Mar;41(3):539-49.

PMID:
12612976
9.

ANCA-associated vasculitis with renal involvement: an outcome analysis.

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.

Nephrol Dial Transplant. 2004 Jun;19(6):1403-11. Epub 2004 Apr 6.

PMID:
15069175
10.

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.

Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M.

Arthritis Res Ther. 2005;7(5):R1072-81. Epub 2005 Jul 13.

11.

Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.

Geffriaud-Ricouard C, Noël LH, Chauveau D, Houhou S, Grünfeld JP, Lesavre P.

Clin Nephrol. 1993 Mar;39(3):125-36.

PMID:
7681736
12.

Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; European Vasculitis Study Group (EUVAS).

Kidney Int. 2002 Jan;61(1):80-9.

14.

Pathogenesis of PR3-ANCA associated vasculitis.

Kallenberg CG.

J Autoimmun. 2008 Feb-Mar;30(1-2):29-36. Epub 2007 Dec 26. Review.

PMID:
18162369
15.

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.

Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW.

Arthritis Rheum. 2000 Sep;43(9):2025-33.

16.

ANCA: serology in Wegener's granulomatosis.

Pradhan VD, Badakere SS, Ghosh K, Almeida A.

Indian J Med Sci. 2005 Jul;59(7):292-300.

PMID:
16062016
17.

Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.

Muller Kobold AC, Kallenberg CG, Tervaert JW.

Br J Rheumatol. 1998 Aug;37(8):901-7.

PMID:
9734683
18.

Anti-myeloperoxidase antibodies in patients with microscopic polyangiitis.

Pradhan VD, Badakere SS, Pawar AR, Almeida AF.

Indian J Med Sci. 2003 Nov;57(11):479-86.

PMID:
14646155
19.
20.

Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).

Wang G, Csernok E, de Groot K, Gross WL.

J Immunol Methods. 1997 Oct 27;208(2):203-11.

PMID:
9433475

Supplemental Content

Support Center